ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. 口頭発表

Carbon Ion Radiotherapy for Unresectable Sacral Chordoma

https://repo.qst.go.jp/records/65005
https://repo.qst.go.jp/records/65005
5fb73e5f-df38-4e75-909f-0e53fa4d0d80
Item type 会議発表用資料 / Presentation(1)
公開日 2013-05-23
タイトル
タイトル Carbon Ion Radiotherapy for Unresectable Sacral Chordoma
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Akamatsu, Hiroko

× Akamatsu, Hiroko

WEKO 640535

Akamatsu, Hiroko

Search repository
Imai, Reiko

× Imai, Reiko

WEKO 640536

Imai, Reiko

Search repository
Kamada, Tadashi

× Kamada, Tadashi

WEKO 640537

Kamada, Tadashi

Search repository
赤松 妃呂子

× 赤松 妃呂子

WEKO 640538

en 赤松 妃呂子

Search repository
今井 礼子

× 今井 礼子

WEKO 640539

en 今井 礼子

Search repository
鎌田 正

× 鎌田 正

WEKO 640540

en 鎌田 正

Search repository
抄録
内容記述タイプ Abstract
内容記述 Purpose: The results of carbon ion radiotherapy for unresectable sacral chordoma were summarized to evaluate efficacy and safety.
Patients and Methods: We performed a retrospective analysis on 175 patients with unresectable sacral chordomas treated with carbon ion radiotherapy between June 1996 and February 2012. All of the patients in this study presented without prior treatment. The applied carbon ion dose ranged from 64.0 GyE to 73.6 GyE (Gray equivalent, median 70.4 GyE) in a total of 16 fixed fractions over four weeks.
Results: The median age of the patients was 67 ranging from 26 to 87. The study group consisted of 55 females and 120 males. The cranial extension of tumor was S2 or higher level in 70% of the patients. The median clinical target volume was 344 cm3. The median follow up period was 59 months. Five-year overall survival and 5-year local control rates were 82% and 79%, respectively. After carbon ion radiotherapy, the ambulatory in 97% of the patients remained with or without supportive devices. Two patients experienced severe skin/soft tissue complications requiring skin grafts.
Conclusion: CIRT appears effective and safe in the management of patients with unresectable sacral chordoma and offers a promising alternative to surgery.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 Heavy Ion in Therapy and Space Radiation Symposium 2013(HITSRS2013)
発表年月日
日付 2013-05-18
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 21:05:08.351178
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3